SNCA and Parkinson disease: The most tested autophagy enhancers are the mTORC1 inhibitor, rapamycin, and the inositol monophosphatase inhibitor, lithium, each of which significantly reduced α-synuclein aggregates and cell death in Parkinson's models [568, 569].